Published in J Cell Sci on July 13, 2012
West Nile virus infection and immunity. Nat Rev Microbiol (2013) 2.40
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus. Hepatology (2015) 2.11
Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. Elife (2014) 1.09
The double-stranded transcriptome of Escherichia coli. Proc Natl Acad Sci U S A (2014) 1.06
Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol (2014) 1.06
Sensing microbial RNA in the cytosol. Front Immunol (2013) 0.99
Activation and evasion of antiviral innate immunity by hepatitis C virus. J Mol Biol (2013) 0.96
Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling. Cytokine (2013) 0.92
MDA5-filament, dynamics and disease. Curr Opin Virol (2015) 0.88
Hepatitis C Virus. Strategies to Evade Antiviral Responses. Future Virol (2015) 0.81
A design principle for a single-stranded RNA genome that replicates with less double-strand formation. Nucleic Acids Res (2015) 0.79
Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5. J Innate Immun (2014) 0.79
Insight into buffalo (Bubalus bubalis) RIG1 and MDA5 receptors: a comparative study on dsRNA recognition and in-vitro antiviral response. PLoS One (2014) 0.78
Proteolysis of MDA5 and IPS-1 is not required for inhibition of the type I IFN response by poliovirus. Virol J (2015) 0.78
Small RNAs tackle large viruses: RNA interference-based antiviral defense against DNA viruses in insects. Fly (Austin) (2013) 0.78
Innate Immunity and Immune Evasion by Enterovirus 71. Viruses (2015) 0.77
Insights into antiviral innate immunity revealed by studying hepatitis C virus. Cytokine (2015) 0.76
Filament assemblies in foreign nucleic acid sensors. Curr Opin Struct Biol (2016) 0.76
Endogenous Retroelements and the Host Innate Immune Sensors. Adv Immunol (2016) 0.75
Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal (2010) 1.91
Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci U S A (2008) 1.77
Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol (2002) 1.70
Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol (2006) 1.67
GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J Virol (2002) 1.58
The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J Cell Sci (2013) 1.33
Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages. Infect Immun (2006) 1.28
Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol (2005) 1.25
Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol (2005) 1.22
Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol (2005) 1.22
Lipid raft microdomains: key sites for Coxsackievirus A9 infectious cycle. Virology (2003) 1.18
The A subunit of type IIb enterotoxin (LT-IIb) suppresses the proinflammatory potential of the B subunit and its ability to recruit and interact with TLR2. J Immunol (2007) 1.18
Association of lipopolysaccharide-binding protein and coronary artery disease in men. J Am Coll Cardiol (2007) 1.14
Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax (2013) 1.12
Ganglioside GD1a is an essential coreceptor for Toll-like receptor 2 signaling in response to the B subunit of type IIb enterotoxin. J Biol Chem (2007) 1.10
TLR8 and TLR7 are involved in the host's immune response to human parechovirus 1. Eur J Immunol (2005) 1.08
Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J Virol (2004) 1.07
Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response. Virulence (2011) 0.98
Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J Neuroimmunol (2002) 0.97
Host adhesive activities and virulence of novel fimbrial proteins of Porphyromonas gingivalis. Infect Immun (2009) 0.95
Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood. J Immunol (2010) 0.95
Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. Am J Respir Cell Mol Biol (2013) 0.95
Cell surface molecular chaperones as endogenous modulators of the innate immune response. Novartis Found Symp (2008) 0.89
A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains. J Immunol (2008) 0.88
Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array. Mediators Inflamm (2006) 0.87
Activation of human meningeal cells is modulated by lipopolysaccharide (LPS) and non-LPS components of Neisseria meningitidis and is independent of Toll-like receptor (TLR)4 and TLR2 signalling. Cell Microbiol (2005) 0.86
Lipid-raft-dependent Coxsackievirus B4 internalization and rapid targeting to the Golgi. Virology (2004) 0.86
Coxsackie B viruses use multiple receptors to infect human cardiac cells. J Med Virol (2004) 0.83
Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol (2006) 0.81
MARCKS as a negative regulator of lipopolysaccharide signaling. J Immunol (2012) 0.80
Modulation of toll-like receptor signalling as a new therapeutic principle. Mediators Inflamm (2011) 0.77
Toll-like receptor polymorphisms and carotid artery intima-media thickness. Stroke (2007) 0.76
Visualising PAMP-PRR interactions using nanoscale imaging. Methods Mol Biol (2012) 0.75
Innate recognition of bacteria: potential therapeutic targets for bacterial sepsis. Expert Rev Clin Immunol (2006) 0.75
Septic shock caused by Streptococcus pneumoniae in a post-splenectomy patient successfully treated with recombinant human activated protein C. Scand J Infect Dis (2006) 0.75